TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.9200
+0.0201 (2.23%)
At close: Jun 18, 2026, 4:00 PM EDT
0.9301
+0.0101 (1.10%)
After-hours: Jun 18, 2026, 7:07 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $60.12 million as of June 18, 2026. Its market cap has decreased by -40.31% in one year.
Market Cap
60.12M
Enterprise Value
24.60M
1-Year Change
-40.31%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $60.12M, a decrease of -83.26%. That is a compound annual growth rate of -30.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 60.12M | 5.95% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 65.36M |
| MediciNova | 64.97M |
| Seres Therapeutics | 64.01M |
| iBio, Inc. | 61.08M |
| MiNK Therapeutics | 60.48M |
| PMV Pharmaceuticals | 60.26M |
| Entera Bio | 59.56M |
| Filana Therapeutics | 58.94M |